logo
DEA's Thomas Prevoznik Fails Again: Cannabis Users Poisoned While Pharmaceutical Cannabis Remains Blocked

DEA's Thomas Prevoznik Fails Again: Cannabis Users Poisoned While Pharmaceutical Cannabis Remains Blocked

Associated Press21 hours ago
While the DEA's Thomas Prevoznik Turned a Blind Eye, American Cannabis Users Were Poisoned: How the DEA Regulatory Failure and Inaction Enabled a Public Health Crisis.
WASHINGTON, D.C. / ACCESS Newswire / July 4, 2025 / The Drug Enforcement Administration (DEA) is asleep at the wheel - or worse, willfully negligent - as contaminated cannabis floods state markets, consumers are poisoned, and legitimate pharmaceutical research is actively blocked by the very agency tasked with protecting public health.
At the center of this national disgrace is DEA's Deputy Administrator Thomas Prevoznik, the long-time bureaucrat at the helm of the DEA's Diversion Control Division. While Prevoznik parades around on taxpayer-funded panels pretending to safeguard public safety, the truth is undeniable: the DEA has utterly failed its mission. As stated on the DEA website:
'The mission of DEA's Diversion Control Division is to prevent, detect, and investigate the diversion of controlled pharmaceuticals and listed chemicals from legitimate sources while ensuring an adequate and uninterrupted supply for legitimate medical, commercial, and scientific needs'.
State Cannabis Chaos Exposes DEA Incompetence
The latest scandal comes out of Massachusetts, where state regulators just suspended the license of Assured Testing Laboratories -one of the largest cannabis labs in the state-after uncovering what they describe as an 'intentional effort to conceal' failing safety results on cannabis products.
The lab, which tested 25% of all cannabis in the state, was caught falsifying reports, hiding contamination, and greenlighting dangerous products that should have failed mandatory yeast, mold, and microbial standards. Thousands of cannabis products were put into consumer hands without accurate safety testing.
Yet not a word from the DEA.
Not a single enforcement action.
No national recall.
No intervention.
The DEA's Mission: Betrayed from Within
The DEA's own mission is crystal clear:
'To prevent, detect, and investigate the diversion of controlled substances while ensuring an adequate and uninterrupted supply for legitimate medical, commercial, and scientific needs.'
Under Prevoznik's failed leadership, that mission has become a farce.
Why Is Prevoznik Blocking Science While Allowing Poison?
The hypocrisy is staggering:
It's the worst of both worlds:
The public is unprotected and medical innovation is obstructed.
The Human Cost of Prevoznik's Failures
This is not regulation.
This is dereliction of duty.
Time for Accountability: Fire Prevoznik, Reform DEA
The solution is clear:
Thomas Prevoznik must be immediately removed from his position for gross negligence and regulatory malpractice.
The DEA's obstruction of pharmaceutical cannabis research must end.
Oversight of cannabis research should be transferred to agencies that understand science-such as the FDA or NIH.
Congress must investigate how the DEA has allowed the national cannabis market to devolve into chaos while blocking life-saving medicines from reaching patients.
'The DEA's Diversion Control Division, under Prevoznik's leadership, has failed to protect the public, failed to uphold science, and failed to meet even the most basic standards of competence,' said Duane Boise, CEO of MMJ BioPharma Cultivation . 'It's time for the DEA to be held accountable for decades of failure.'
The American People Deserve Better
The DEA exists to serve and protect the public, not to act as a political roadblock while Americans are poisoned and scientific progress is stalled.
Prevoznik failed. The DEA failed.
It's time for Congress, the courts, and the public to take back control.
MMJ is represented by attorney Megan Sheehan.
CONTACT:
Madison Hisey
[email protected]
203-231-8583
SOURCE: MMJ International Holdings
press release
Orange background

Try Our AI Features

Explore what Daily8 AI can do for you:

Comments

No comments yet...

Related Articles

BrightSpring's Onco360 Becomes National Pharmacy Partner for New Cancer, Rare Disease Therapies
BrightSpring's Onco360 Becomes National Pharmacy Partner for New Cancer, Rare Disease Therapies

Yahoo

time44 minutes ago

  • Yahoo

BrightSpring's Onco360 Becomes National Pharmacy Partner for New Cancer, Rare Disease Therapies

BrightSpring Health Services Inc. (NASDAQ:BTSG) is one of the best new stocks to buy now. On June 18, BrightSpring Health Services announced that its specialty pharmacy, called Onco360, has been chosen as the national pharmacy partner for several newly approved therapies. These innovative treatments target advanced cancers and rare genetic disorders. BrightSpring delivers care and clinical solutions to 400,000+ customers, clients, and patients daily across all 50 states. Onco360 will provide access, education, data, and expert support for patients suffering from advanced ovarian and lung cancers, as well as neurofibromatosis type 1. A medical technician using surgical robotics to perform minimally-invasive urologic surgery in an operating room. Onco360 has been selected as a pharmacy partner for the following specific medication therapies: GOMEKLI, which is approved for adult and pediatric patients aged 2 years and older with neurofibromatosis type 1 (NF1) who have symptomatic plexiform neurofibromas/PN not suitable for complete resection; AVMAPKI FAKZYNJA CO-PACK, which is approved for adult patients with KRAS-mutated recurrent low-grade serous ovarian cancer/LGSOC who have received prior systemic therapy; and IBTROZI, which is approved for adult patients with locally advanced or metastatic ROS1-positive non-small cell lung cancer (NSCLC). BrightSpring Health Services Inc. (NASDAQ:BTSG) is a home and community-based healthcare services platform in the US that operates through 2 segments: Pharmacy Solutions and Provider Services. Onco360 is a national, independent Oncology Pharmacy and clinical support services company. While we acknowledge the potential of BTSG as an investment, we believe certain AI stocks offer greater upside potential and carry less downside risk. If you're looking for an extremely undervalued AI stock that also stands to benefit significantly from Trump-era tariffs and the onshoring trend, see our free report on the . READ NEXT: and . Disclosure: None. This article is originally published at Insider Monkey. Error in retrieving data Sign in to access your portfolio Error in retrieving data Error in retrieving data Error in retrieving data Error in retrieving data

Waystar Study Highlights AI's Critical Role, Proven ROI in Healthcare Payments
Waystar Study Highlights AI's Critical Role, Proven ROI in Healthcare Payments

Yahoo

time44 minutes ago

  • Yahoo

Waystar Study Highlights AI's Critical Role, Proven ROI in Healthcare Payments

Waystar Holding Corp. (NASDAQ:WAY) is one of the best new stocks to buy now. On June 23, Waystar announced the findings of a commissioned study conducted by Forrester Consulting. The study is titled 'AI in Healthcare Payments Software: A Strategic Imperative,' and revealed that AI is becoming increasingly critical in revenue cycle management/RCM due to its proven impact and measurable ROI. The research shows acceleration in AI adoption within healthcare. 82% of healthcare leaders now consider AI an integral part of their RCM operations, with 70% identifying it as a top organizational priority. The study also found that AI is delivering improvements in key revenue cycle metrics, such as a 13% to 37% improvement in high-impact areas such as claim accuracy, denial prevention, workforce efficiency, and payment speed. A medical professional with a patient explaining the effects of neurostimulation treatments. Trust in AI is growing, with 60% of decision-makers reporting increased confidence since implementing AI. ~ 70% of healthcare leaders view AI as a high or critical organizational priority, and 60% plan to increase their AI investment. The study is based on responses from 300+ healthcare leaders and highlights a preference for existing RCM software partners when it comes to AI capabilities. Waystar serves ~30,000 clients and represents over 1 million distinct providers, including 16 of the top 20 institutions on the US News Best Hospitals list. Waystar Holding Corp. (NASDAQ:WAY) develops a cloud-based software solution for healthcare payments. While we acknowledge the potential of WAY as an investment, we believe certain AI stocks offer greater upside potential and carry less downside risk. If you're looking for an extremely undervalued AI stock that also stands to benefit significantly from Trump-era tariffs and the onshoring trend, see our free report on the . READ NEXT: and . Disclosure: None. This article is originally published at Insider Monkey. Error in retrieving data Sign in to access your portfolio Error in retrieving data Error in retrieving data Error in retrieving data Error in retrieving data

Elderly woman found tied up and brutally attacked in Shreveport
Elderly woman found tied up and brutally attacked in Shreveport

Yahoo

timean hour ago

  • Yahoo

Elderly woman found tied up and brutally attacked in Shreveport

DISCLAIMER: All persons are presumed innocent until proven guilty SHREVEPORT, La. (KTAL/KMSS) – A 91-year-old woman is currently fighting for her life after what police describe as a violent home invasion. On July 2, 2025, Shreveport Police officers say they responded to a disturbing scene in the 2400 block of Sommersworth Drive. A 91-year-old woman was found severely beaten, tied up, and locked inside a closet in her own home. She was barely clinging to life when she was discovered. Detectives with the department's Violent Crimes Unit immediately launched an intensive investigation. In just hours, investigators identified 24-year-old Kendrell Thomas as the suspect. Troubles mount for suspect who allegedly robbed Shreveport drive-in With help from the Narcotics Unit and federal partners, Thomas was located at the Stone Vista Apartments and taken into custody without incident. Thomas faces the following charges: Attempted First-Degree Murder Aggravated Kidnapping Second-Degree Battery Home Invasion 'This was a heartless, violent attack on one of our most vulnerable residents,' said Chief Wayne Smith. 'Thanks to the outstanding work of our officers and detectives, the suspect is now in custody and will face justice.' The victim remains hospitalized in critical condition. Anyone with additional information is urged to contact the Shreveport Police Department at 318-673-7300. Copyright 2025 Nexstar Media, Inc. All rights reserved. This material may not be published, broadcast, rewritten, or redistributed.

DOWNLOAD THE APP

Get Started Now: Download the App

Ready to dive into a world of global content with local flavor? Download Daily8 app today from your preferred app store and start exploring.
app-storeplay-store